No photo of Melita Kenealy

Melita Kenealy

Dr

20152024
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2017 2024

A phase 3, open-label, randomised study to compare the efficacy and safety of luspatercept (Ace-536) versus epoetin alfa for the treatment of anaemia due to Ipss-R very low, low or intermediate risk myelodysplastic syndromes (MDS) in ESA naive subjects who require red blood cell transfusions [ACE-536-MDS-002]

Kenealy, M. & Baker, E.

20/12/18 → 31/12/24

Project: Research

The PRECISE assay: Personalised medicine for cancer patients using next-generation sequencing

To, S. Q. G., Azad, A., Shortt, J., Wei, A., Shackleton, M. & Kenealy, M.

1/12/17 → 1/12/20

Project: Research

Research Output 2015 2015

Complete remission of Waldenström's associated generalized crystal-storing histiocytosis of IgM lambda subtype with bortezomib-based combination chemotherapy

Baird, S. M., Kenealy, M. K. & Hoy, R., 2 Nov 2015, In : Leukemia and Lymphoma. 56, 11, p. 3233-3235 3 p.

Research output: Contribution to journal › Letter › Other › peer-review